Tag: Ann Dennis

Since 2008, new HIV diagnoses in the US have been reduced by about half; however, progress is not equally distributed. In 2022, only about 65% of people diagnosed with HIV in the US—and North Carolina—were virally suppressed, falling short of the national target of 95% viral suppression. Southern states, including...

Briefly summarize your background and interests, and how you came to the Institute. I originally trained as a biomedical engineer and gained experience with in-host modeling of influenza during my Master’s degree at the University of Virginia. I was interested in continuing to work on infectious disease modeling, but wanted...

The CDC’s Social Network Strategy (SNS) is an evidence-supported approach to increase reach for HIV testing among members of marginalized populations. Carol Golin, MD, and Ann M. Dennis, MD, MS, explored key barriers and facilitators prior to implementing an enhanced SNS (eSNS) to increase access to a broader range of HIV...

Ann Dennis, MD, MS, a member of the Institute for Global Health and Infectious Disease (IGHID) and associate professor of medicine, focuses on the clinical and epidemiologic aspects of HIV/AIDS, particularly among minority and immigrant populations. Dennis will soon be starting the implementation phase of the RESPOND Carolinas study, to improve...

HIV virus eradication is a complex health challenge due to its long-lived persistence and how it hides in latently infected cells that escape the body’s immune system. Effective HIV treatments have decreased the likelihood of someone developing AIDS, while helping individuals live long and healthy lives without transmission to sexual...

Global health research is a collaborative process, and each researcher at the Institute for Global Health & Infectious Diseases contributes a piece to solving the puzzle of disease and morbidity. With a new academic year underway, read what some of our investigators are working on to improve the health of global populations....